AKT1 and liver dysplastic nodule: Accordingly, targeting the activation of PI3K/Akt/mTOR signaling and the expression of phosphorylated p70S6K (p-p70S6K) in the kidneys could be therapeutic mechanisms for ameliorating the early glomerular lesions of DN.